ARGX · NASDAQ · Biotechnology

argenx (ADR) (ARGX)

Develops antibody medicines for severe autoimmune diseases around the VYVGART franchise.

$951.35
vs last close−12.44 (−1.29%)
  1. What Makes Argenx (ARGX) a New Buy Stock

    Zacks Investment Research